METHODS FOR DETECTING AND MEASURING AGGREGATION

    公开(公告)号:US20160266142A1

    公开(公告)日:2016-09-15

    申请号:US15092499

    申请日:2016-04-06

    申请人: Theranos, Inc.

    摘要: Methods, compositions, systems, and devices are provided for performing and analyzing agglutination assays. In one aspect, methods for image analysis of agglutination assays are provided. In another aspects, methods for performing agglutination assays are provided. In one aspect, the methods may be used for the detection of various molecules, including viruses or antibodies against a virus. In another aspect, the methods can be used to determine effective immunization of a subject.

    Assay
    3.
    发明申请
    Assay 审中-公开
    测定

    公开(公告)号:US20070292839A1

    公开(公告)日:2007-12-20

    申请号:US10577358

    申请日:2004-11-01

    申请人: David Parker

    发明人: David Parker

    IPC分类号: C12Q1/70 G01N33/556

    CPC分类号: G01N33/6854 G01N2469/20

    摘要: The invention relates to a method of determining the amount or presence of antibodies to an immunogen in a blood sample comprising at least the steps of detecting the amount or presence of plasma antibodies or parts thereof and lymphocyte antibodies or parts thereof in said sample, wherein said plasma and lymphocyte antibodies are detected together or in separate assays and determination of their combined amount or presence determines the amount or presence of antibodies to said immunogen. Uses of the method in high throughput screening, screening of blood bank samples and in diagnosis are also provided.

    摘要翻译: 本发明涉及一种确定血液样品中免疫原抗体的量或存在的方法,包括至少检测所述样品中血浆抗体或其部分的量或存在的量以及淋巴细胞抗体或其部分的步骤,其中所述 血浆和淋巴细胞抗体一起检测或在单独的测定中检测,并且其组合量或存在的测定决定了抗体对所述免疫原的量或存在。 还提供了在高通量筛选,血库样本筛选和诊断中使用该方法。

    Hydrazine derivatized cells
    4.
    发明授权
    Hydrazine derivatized cells 失效
    肼衍生细胞

    公开(公告)号:US5637472A

    公开(公告)日:1997-06-10

    申请号:US391869

    申请日:1995-02-22

    摘要: A method is provided for the preparation of semisolid particles or cells that have been chemically derivatized resulting in hydrazide functionalities covalently incorporated onto cell surface membrane molecules of the semisolid particles or cells, as well as a method for determining the levels of hydrazide groups on the particles or cells. The method involves the preparation and analysis of red blood cells chemically derivatized in such a manner that hydrazide functionalities have been covalently incorporated onto the cell membrane molecules, the preparation of hydrazine derivatized cells and the use thereof of the novel cells in agglutination reactions to promote the attachment of antigens and antibodies to the hydrazine derivatized cells without loss of antibody activity or the blocking of the etitope of interest.

    摘要翻译: 提供了一种制备半固体颗粒或细胞的方法,该半固体颗粒或细胞被化学衍生化,导致共价掺入到半固体颗粒或细胞的细胞表面膜分子上的酰肼官能团,以及确定颗粒上酰肼基团水平的方法 或细胞。 该方法涉及红细胞的制备和分析,其方法是将酰肼官能团共价掺入到细胞膜分子上,制备肼衍生化细胞,以及在凝集反应中使用新细胞促进 将抗原和抗体连接到肼衍生化的细胞上,而不会损失抗体活性或阻断目的蛋白酶。

    METHODS FOR DETECTING AND MEASURING AGGREGATION
    7.
    发明申请
    METHODS FOR DETECTING AND MEASURING AGGREGATION 审中-公开
    检测和测量聚集的方法

    公开(公告)号:US20150198591A1

    公开(公告)日:2015-07-16

    申请号:US14598498

    申请日:2015-01-16

    申请人: Theranos, Inc.

    摘要: Methods, compositions, systems, and devices are provided for performing and analyzing agglutination assays. In one aspect, methods for image analysis of agglutination assays are provided. In another aspects, methods for performing agglutination assays are provided. In one aspect, the methods may be used for the detection of various molecules, including viruses or antibodies against a virus. In another aspect, the methods can be used to determine effective immunization of a subject.

    摘要翻译: 提供方法,组合物,系统和装置用于进行和分析凝集测定。 在一个方面,提供了用于凝集测定的图像分析的方法。 在另一方面,提供了用于进行凝集测定的方法。 在一个方面,所述方法可用于检测各种分子,包括针对病毒的病毒或抗体。 另一方面,该方法可用于确定受试者的有效免疫。

    Virus hemagglutination-inhibition reaction
    10.
    发明授权
    Virus hemagglutination-inhibition reaction 失效
    病毒血凝抑制反应

    公开(公告)号:US4298346A

    公开(公告)日:1981-11-03

    申请号:US085641

    申请日:1979-01-29

    申请人: Homu Ito

    发明人: Homu Ito

    IPC分类号: G01N33/556 G01N33/48

    摘要: The nonspecific hemagglutination inhibitors and natural hemagglutinins in a test serum for a virus hemagglutination-inhibition reaction can be removed at one stroke in a convenient procedure by pretreating the test serum with a composition containing both fixed avian erythrocytes and kaolin particles.

    摘要翻译: 用于病毒血凝抑制反应的测试血清中的非特异性血凝素抑制剂和天然血凝素可以通过用含有固定的禽类红细胞和高岭土颗粒的组合物预处理测试血清在一个方便的程序中一次除去。